ММВБ 2 675 0,0%  Nasdaq 8 004 -0,2%  Биткойн 10 215 0,8%  USD/RUB 65,6083 -0,3% 
РТС 1 283 0,2%  S&P500 2 926 0,1%  Нефть 60,3 -0,1%  EUR/RUB 72,7208 -0,3% 
Dow 26 290 0,3%  FTSE100 7 128 -1,1%  Золото 1 500 0,5%  EUR/USD 1,1084 0,0% 

Курс акций TxCell SA [ISIN: FR0010127662]

купить
продать

TxCell SA - Профиль

TxCell SA is a biotechnology company. The company engages in the research and development of cellular immunotherapy for chronic inflammatory and autoimmune diseases. Its pipeline consists of Ovasave, col treg, lupus, transplantation and car treg dermatology. The company was founded on April 12, 2001 and is headquartered in Valbonne-Sophia Antipolis, France.

Адрес

Les Cardoulines HT1, 06560 Valbonne-Sophia Antipolis
а/я:
Телефон: 33497218300
Факс: 33493641580
Вэб: http://www.txcell.com/index.php/fr

Менеджмент

Raphael Flipo
CFO, Chief Administrative Officer & VP
François Meyer, PhD
Chairman & Head-Research
Bernard Daugeras, PhD
Director
Laurent Arthaud
Director
Thibaut Roulon, PhD
Director
Marie-Laure Garrigues
Director
Laurent Higueret, PhD
Director
Caroline Courme
Director-Investor Relations & Communication
Marie-Yvonne Landel-Meunier MBA, CPA
Independent Director
Pierre Heimendinger, PhD
Vice President-Process Development
Catherine Mathis, PhD
Vice President-Regulatory Affairs
Nathalie Belmonte, PhD
Vice President-Research Operations

Добавить или редактировать инструмент